Rein Therapeutics (RNTX) Stock Price & Financial Analysis
Rein Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Rein Therapeutics
What is the current stock price for RNTX?
As of the latest trading session, RNTX stock trades at $1.21. The 52-week range is $1.02–$2.40, with a day range of $1.11–$1.33.
What is the P/E ratio for RNTX?
The P/E ratio (Price-to-Earnings) for RNTX is shown in the Key Statistics section. This valuation metric helps compare Rein Therapeutics Inc. to industry peers.
Does RNTX pay dividends?
Rein Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for RNTX?
Based on 1 analyst, the consensus for RNTX is Hold. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of RNTX?
Rein Therapeutics's market capitalization is $31.9M, classifying it as a micro-cap company. Rein Therapeutics operates in the Healthcare sector within the Biotechnology industry.